CervoMed Inc.
CRVO | NASDAQ
$2.43
+$0.02 (+0.83%)
Sep 22, 2026, 11:01 AM ET · Market open
TTM Period Ending | Q2 2026 Jun 29, 2026 | Q1 2026 Mar 30, 2026 | Q4 2025 Dec 30, 2025 | Q3 2025 Sep 29, 2025 | Q2 2025 Jun 29, 2025 | Q1 2025 Mar 30, 2025 | Q4 2024 Dec 30, 2024 | Q3 2024 Sep 29, 2024 | Q2 2024 Jun 29, 2024 | Q1 2024 Mar 30, 2024 | Q4 2023 Dec 30, 2023 | Q3 2023 Sep 29, 2023 | Q2 2023 Jun 29, 2023 | Q1 2023 Mar 30, 2023 | Q4 2022 Dec 30, 2022 | Q3 2022 Sep 29, 2022 | Q2 2022 Jun 29, 2022 | Q1 2022 Mar 30, 2022 | Q4 2021 Dec 30, 2021 | Q3 2021 Sep 29, 2021 | Q2 2021 Jun 29, 2021 | Q1 2021 Mar 30, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 322.57K | 322.57K | 322.57K | 322.57K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost of Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit | 322.57K | 322.57K | 322.57K | 322.57K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Income | -31.16M | -31.1M | -28.29M | -27.2M | -24.56M | -20.94M | -18.23M | -13.47M | -10.75M | -8.98M | -7.81M | -9.58M | -7.81M | -10.83M | -13.95M | -13.17M | -24.96M | -24.55M | -24.68M | -25.3M | -17.88M | -17.7M |
Interest Income | 812.01K | 1.08M | 1.34M | 1.63M | 1.96M | 2.27M | 1.94M | 1.52M | 925.39K | 264.66K | 219.43K | 273.63K | 247.49K | 285.16K | 277.56K | 104.71K | 133.9K | 133.75K | 146.35K | 171.37K | 149.89K | 120.57K |
Pretax Income | -30.35M | -30.04M | -26.97M | -25.58M | -22.61M | -18.67M | -16.29M | -11.95M | -5.04M | -4.15M | -2.17M | -3.89M | -6.92M | -9.68M | -13.68M | -13.07M | -24.83M | -24.42M | -24.54M | -25.13M | -17.73M | -17.58M |
Net Income | -30.35M | -30.04M | -26.97M | -25.58M | -22.61M | -18.67M | -16.29M | -11.95M | -5.04M | -4.15M | -2.17M | -3.89M | -6.92M | -9.68M | -13.68M | -13.07M | -24.39M | -23.98M | -24.1M | -24.68M | -16.92M | -16.27M |
Selling & General & Admin | 10.17M | 11.08M | 10.48M | 10.29M | 10.18M | 9.42M | 9.17M | 8.97M | 9.17M | 7.65M | 6.52M | 6.75M | 4.91M | 6.06M | 7.18M | 6.77M | 8.13M | 7.83M | 7.45M | 6.99M | 7.17M | 6.79M |
Research & Development | 21.33M | 22.11M | 21.82M | 23.07M | 22.16M | 20.82M | 18.8M | 14.57M | 11.23M | 9.42M | 8.44M | 7.49M | 6.03M | 6.18M | 6.77M | 6.37M | 8.14M | 8.01M | 8.5M | 9.58M | 10.61M | 10.81M |
Other Expenses | -8.73K | -1.77M | -3.68M | -5.84M | -7.78M | -9.31M | -9.74M | -10.07M | -9.65M | -8.08M | -7.14M | -4.65M | -3.13M | -1.41M | n/a | 26.11K | 8.68M | 8.71M | 8.73M | 8.73M | 97.33K | 100.6K |
Operating Expenses | 31.49M | 31.43M | 28.62M | 27.53M | 24.56M | 20.94M | 18.23M | 13.47M | 10.75M | 8.98M | 7.81M | 9.58M | 7.81M | 10.83M | 13.95M | 13.17M | 24.96M | 24.55M | 24.68M | 25.3M | 17.88M | 17.7M |
Interest Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 8.87K | 8.87K | 8.87K | 8.87K | n/a | n/a | n/a |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 24.81M | 31.43M | 28.62M | 27.53M | 24.56M | 20.94M | 18.23M | 13.47M | 10.75M | 8.98M | 7.81M | 9.58M | 7.81M | 10.83M | 13.95M | 13.17M | 24.96M | 24.55M | 24.68M | 25.3M | 17.88M | 17.7M |
Income Tax Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -443.89K | -443.89K | -443.89K | -443.89K | -805.68K | -1.31M |
Shares Outstanding (Basic) | 10.24M | 9.26M | 9.25M | 9.25M | 8.95M | 8.7M | 8.7M | 8.7M | 8.7M | 6.17M | 5.68M | 3.31M | 1.36M | 1.36M | 1.36M | 1.36M | 1.36M | 1.36M | 1.36M | 1.36M | 1.36M | 1.11M |
Shares Outstanding (Diluted) | 10.24M | 9.26M | 9.25M | 9.25M | 8.95M | 8.7M | 8.7M | 8.7M | 8.7M | 6.17M | 5.68M | 3.77M | 1.36M | 1.36M | 1.36M | 1.36M | 1.36M | 1.36M | 1.36M | 1.36M | 1.36M | 1.11M |
EPS (Basic) | -3.21 | -3.27 | -2.97 | -2.87 | -2.58 | -2.15 | -2 | -1.65 | -0.45 | -1.73 | -4.33 | -6.91 | -9.26 | -10.79 | -11.11 | -10.67 | -17.95 | -17.65 | -18.53 | -20.73 | -16.95 | -21.49 |
EPS (Diluted) | -3.21 | -3.27 | -2.97 | -2.87 | -2.58 | -2.15 | -2 | -1.65 | -1.80 | -3.08 | -5.68 | -8.26 | -9.26 | -10.79 | -11.11 | -10.67 | -17.95 | -17.65 | -18.53 | -20.73 | -16.95 | -21.49 |
EBITDA | -30.46M | -30.04M | -26.97M | -25.58M | -22.61M | -18.67M | -16.29M | -6.42M | 479.69K | 1.37M | 3.35M | -3.89M | -6.92M | -9.68M | -13.68M | -13.04M | -16.19M | -15.76M | -15.89M | -16.51M | -17.73M | -17.6M |
EBIT | -23.78M | -30.04M | -26.97M | -25.58M | -22.61M | -18.67M | -16.29M | -6.42M | 479.69K | 1.37M | 3.35M | -3.89M | -6.92M | -9.68M | -13.68M | -13.07M | -16.24M | -15.83M | -15.98M | -16.6M | -17.82M | -17.7M |
Depreciation & Amortization | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 26.11K | 45.21K | 68.97K | 93.42K | 92.24K | 97.33K | 100.6K |
Add to Watchlist
Select watchlists to add or remove CRVO